Clinical Trials of Prophylactic Implantable Defibrillator Therapy in Patients with Nonischemic Cardiomyopathy: What have We Learned and What can We Expect from Future Trials?

Author： Grimm W.  

Publisher： Springer Publishing Company

ISSN： 1385-2264

Source： Cardiac Electrophysiology Review, Vol.7, Iss.4, 2003-12, pp. : 463-467

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

What we have learned from risk charts?

By Arslan Eren   Erdine Serap  

Future Cardiology, Vol. 6, Iss. 3, 2010-05 ,pp. : 285-287

Future Medicine

Access to resources Recommend Favorite

Implantable Cardioverter Defibrillator Therapy in Patients with Ischemic or Non-Ischemic Cardiomyopathy and Nonsustained Ventricular Tachycardia

By Evonich Rudolph F.   Maheshwari Alok   Gardiner Joseph C.   Khasnis Atul   Kantipudi Sricharan   Ip John H.   Grimes Denise   Hayter Gregory   Thakur Ranjan K.  

Journal of Interventional Cardiac Electrophysiology, Vol. 11, Iss. 1, 2004-08 ,pp. : 59-65

Springer Publishing Company

Access to resources Recommend Favorite

Radiation-Induced Thyroid Cancer: What We Have Learned From Chernobyl

By  

Endocrine Pathology, Vol. 17, Iss. 4, 2006-12 ,pp. : 307-318

Humana Press, Inc

Access to resources Recommend Favorite

What We have Learned about Pain from Rodent Models of Arthritis?

By  

Current Rheumatology Reviews, Vol. 6, Iss. 3, 2010-08 ,pp. : 194-207

Bentham Science Publishers

Access to resources Recommend Favorite

Pain management today—what have we learned?

By Langford Richard  

Clinical Rheumatology, Vol. 25, Iss. 1, 2006-07 ,pp. : 2-8

Springer Publishing Company

Access to resources Recommend Favorite